Biospecimen Repository for Cardiac Arrh… | Clinical Trial

Key information

Conditions

Arrhythmias, Cardiac Arrhythmia, Sinus Atrial Fibrillation Atrial Premature Complexes Autonomic Nervous System Diseases Cardiac Complexes, Premature Cardiac Conduction System Disease Cardiovascular Diseases Consciousness Disorders Death Heart Block Heart Diseases Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Orthostatic Intolerance Pathologic Processes Pathological Conditions, Signs and Symptoms Postural Orthostatic Tachycardia Syndrome Primary Dysautonomias Sick Sinus Syndrome Signs and Symptoms Syncope Tachycardia Tachycardia, Supraventricular Tachycardia, Ventricular Unconsciousness Ventricular Fibrillation Ventricular Premature Complexes

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

Location status: Recruiting

Location contact

David R. Van Wagoner, Ph.D.

SUB_INVESTIGATOR

John Barnard, Ph.D.

SUB_INVESTIGATOR

Jonathan D. Smith, Ph.D.

SUB_INVESTIGATOR

Mina K. Chung, MD

PRINCIPAL_INVESTIGATOR

About this study

The long-term objective of this research is to find genes and biologic pathways causing arrhythmia syndromes and other diseases or conditions. In order to achieve this objective the investigators will collect comprehensive phenotypic data and corresponding blood and/or tissue samples into a biorepository registry of patients, presenting for cardiac arrhythmia evaluation and/or treatment, and control subjects without arrhythmias. This biorepository will be composed of two parts: 1) An Arrhythmia Biorepository of blood and tissue from patients undergoing arrhythmia procedures, cardiac surgery, or inpatient or outpatient evaluations for arrhythmias, and 2) A Collaborative Sample Biorepository for de-identified samples and data from outside institutions and clinical trials.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male or female at least 18 years old
Subjects with a history of or current cardiac arrhythmia, family members of subjects with cardiac arrhythmias, or no cardiac arrhythmia if a Control Subject.

Exclusion criteria

Subjects previously enrolled in the Arrhythmia BioBank

Treatment and study plan

Primary outcomes

Genetic variants associated with arrhythmias

Time frame: Baseline

Genome-wide association study of arrhythmias

Study contacts

Contact information is provided by the study sponsor or research team.

Mina K. Chung, MD

CONTACT

[email protected]

216.444.2290

Sponsors and collaborators

Lead sponsor

The Cleveland Clinic

Other

Registry information

Official study title

Cleveland Clinic Arrhythmia Biospecimen Repository (Cleveland Clinic Arrhythmia BioBank)

Important dates

Study start: 2009
Primary completion: 2035
Study completion: 2035
First posted: Jun 17, 2009
Registry last updated: Sep 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting